Premium
Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has reached an agreement to buy out the minority shareholders of New York Stock Exchange-listed Taro Pharmaceutical Industries and thereby take it private in a deal that would cost the Mumbai-based firm as much as $592 million (Rs 3,250 ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
